Skip to main content
OpenTrials
Completed

NCT Number: NCT00416611

IMPlementation of gUideLines for the Management of Arterial hypertenSION. The IMPULSION Study

The objective of this protocol is to improve awareness, treatment, and control of arterial hypertension, within primary prevention of target organ damage, by implementing guidelines, after training of the participating physicians.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

High Blood Pressure Cardiovascular Diseases Hypertension Vascular Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hellenic Atherosclerosis Society

Thessaloniki, 55132, Greece

About this study

Physicians from 20 hospitals and 40 health centres (primary health care settings) were trained to implement guidelines in treating arterial hypertension.

There will be a baseline recording of patients with arterial hypertension and then physicians will have to complete a one page form (by ticking pre-specified boxes) about the baseline status of the patients and will have to report the measures they took to improve awareness, treatment, and effective control of arterial hypertension. After a six month effort, physicians will have to complete the same form at study completion. Previous training of physicians and the fact that they will have to report their success in treating hypertension will hopefully contribute to an increase in number of hypertensive patients at blood pressure target, and will minimise the target organ damage. The estimated reduction in coronary heart disease risk will be evaluated by a comparison of this risk (as evaluated by a risk engine, i.e. PROCAM) at study completion with that of baseline.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Arterial hypertension as defined by the JNC 7 report

Exclusion criteria

  • Pregnancy
  • Lactation
  • Malignancies with small life expectancy
  • Unwillingness to participate

Treatment and study plan

Implementation of guidelines

Behavioral

Primary outcomes

  1. Efficacy in arterial hypertension control

    Time frame: 6 months

  2. Efficacy in reducing estimated risk of coronary heart disease

    Time frame: 6 months

Secondary outcomes

  1. Cost effectiveness of arterial hypertension control

    Time frame: 6 months

  2. Differences between primary and secondary health care settings as well as teaching hospitals

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

Hellenic Atherosclerosis Society

Other

Registry information

Acronym: IMPULSION

Important dates

Study start
2006
Primary completion
2007
Study completion
2007
First posted
Dec 28, 2006
Registry last updated
Jan 29, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.